Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - Re: Brief Arguments that will impact the decision of the USPTO/Bluewing

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Back To Forum List View

Brief Arguments that will impact the decision of the USPTO

Bluewing1

Apr 18, 2008 03:54PM

Re: Brief Arguments that will impact the decision of the USPTO

B4-2012_please

Apr 18, 2008 06:07PM

srandl

Rank: Vice President [?]

Points: 5514 [?]

Votes: 79 Score: 3.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Brief Arguments that will impact the decision of the USPTO/Bluewing

in response to

Brief Arguments that will impact the decision of the USPTO

Bluewing1

posted on Apr 19, 2008 07:18AM

Excellent post Bluewing. This would indicate that TPL/PTSC would have the upper hand on the 584 vs. ARM as well right?

All the best,

Steve

2 Recommendations

Repost:by bluewing , Brief Arguments that will impact the decision of the USPTO

B4-2012_please

Apr 20, 2008 07:44AM

Re: Repost:by bluewing , Brief Arguments that will impact the decision of the USPTO